Knowledge Distillery

Is the Frontal Lobe the Primary Target of SARS-CoV-2?

Acute ischemic stroke in patients with COVID-19: an analysis from Get With The Guidelines-Stroke

Seroprevalence of SARS-CoV-2 in Parkinson’s disease patients: a case-control study

Brainstem clinical and neurophysiological involvement in COVID-19

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

In this paper recently published in Neurology, the authors aimed to determine whether neurological manifestations are common in hospitalised COVID-19…

SARS-CoV-2 has currently precipitated the COVID-19 global health crisis.

Whilst respiratory failure in COVID-19 arises from severe interstitial lung involvement, SARS-CoV-2 likely spreads also through the nervous system.

The impact of the COVID‐19 pandemic on PD patients is yet to be determined. Studies showed diverse prevalence and outcomes among PD patients.

Studies suggest an increased risk of adverse outcomes among patients with acute ischemic stroke (AIS) and COVID-19.

Acute delirium and other neuropsychiatric symptoms have frequently been reported in COVID-19 patients and are variably referred to as acute…

The purpose of this review was to provide an overview on current knowledge of neurological symptoms and complications of COVID-19, and to suggest…